Bello Akintunde Olatokumbo 4
4 · Xilio Therapeutics, Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Bello Akintunde Olatokumbo
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-10+62,000→ 62,000 totalExercise: $0.70Exp: 2035-06-09→ Common Stock (62,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 10, 2025 and will vest in three equal installments on June 10, 2026, June 10, 2027 and June 10, 2028, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.